Healthequity (HQY) Short term Debt (2019 - 2023)

Healthequity has reported Short term Debt for 5 years, with the latest figure at $17.5 million in Q1 2023.

• On a quarterly basis, Short term Debt rose 100.0% year-over-year to $17.5 million in Q1 2023; TTM through Jan 2023 was $17.5 million, a 100.0% increase from a year earlier, with the FY2023 full-year figure at $17.5 million, up 100.0% from the prior year.
• Short term Debt was $17.5 million for Q1 2023 at Healthequity, up from $15.3 million in the prior quarter.
• The five-year high for Short term Debt was $78.1 million in Q3 2021, with the low at $6.6 million in Q4 2021.
• Average Short term Debt over 5 years is $36.4 million, with a median of $35.2 million recorded in 2019.
• The sharpest annual moves came in 2021 and 2022: Short term Debt plunged 89.5% in 2021, then soared 133.32% in 2022.
• Over 5 years, Short term Debt stood at $31.2 million in 2019, then jumped by 100.0% to $62.5 million in 2020, then slumped by 89.5% to $6.6 million in 2021, then jumped by 133.32% to $15.3 million in 2022, then increased by 14.28% to $17.5 million in 2023.
• The last three Short term Debt figures came in at $17.5 million (Q1 2023), $15.3 million (Q4 2022), and $13.1 million (Q3 2022), per Business Quant data.